CDB20:0002930 SNCA — LAG3

Experimentally validated in Human, Mouse; Orthology-inferred in Human, Rat, Frog, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep, Mouse

Title

Journal:; Year Published:

Abstract

Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.

Science, 2016; PubMed, Homo sapiens SNCA — Homo sapiens LAG3
ABSTRACT: Emerging evidence indicates that the pathogenesis of Parkinson's disease (PD) may be due to cell-to-cell transmission of misfolded preformed fibrils (PFF) of α-synuclein (α-syn). The mechanism by which α-syn PFF spreads from neuron to neuron is not known. Here, we show that LAG3 (lymphocyte-activation gene 3) binds α-syn PFF with high affinity (dissociation constant = 77 nanomolar), whereas the α-syn monomer exhibited minimal binding. α-Syn-biotin PFF binding to LAG3 initiated α-syn PFF endocytosis, transmission, and toxicity. Lack of LAG3 substantially delayed α-syn PFF-induced loss of dopamine neurons, as well as biochemical and behavioral deficits in vivo. The identification of LAG3 as a receptor that binds α-syn PFF provides a target for developing therapeutics designed to slow the progression of PD and related α-synucleinopathies.
Basic Information on SNCA
Ligand Name: synuclein alpha
Other Symbols: PARK1, PARK4, NACP, PD1
Ligand Location: secreted based on uniprot
HGNC Gene Symbol Report: SNCA
GeneCards: SNCA
HGNC Gene Group: unknown
Interactions with other Receptors for SNCA
Basic Information on LAG3
Receptor Name: lymphocyte activating 3
Other Symbols: CD223
Receptor Location: cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: LAG3
GeneCards: LAG3
Interactions with other Ligands for LAG3